This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
Benjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion
This week’s Current Climate, which every Saturday brings you the latest news about the business of sustainability.
London-based Mytos has developed a way to automate aspects of biological research that are still tediously done by hand.
The new contest aims to spur innovation into longer ‘healthspans’ with treatments that can actually reverse age-related degradation in body, mind and immune system.